Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.

por Sanna Siltanen, Tiina Wahlfors, Martin Schindler, Outi R Saramäki, John Patrick Mpindi, Leena Latonen, Robert L Vessella, Teuvo L J Tammela, Olli Kallioniemi, Tapio Visakorpi, Johanna Schleutker
Publicado 2011

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

por Leena Latonen, Ebrahim Afyounian, Antti Jylhä, Janika Nättinen, Ulla Aapola, Matti Annala, Kati K. Kivinummi, Teuvo T. L. Tammela, Roger W. Beuerman, Hannu Uusitalo, Matti Nykter, Tapio Visakorpi
Publicado 2018